Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing. 1996

S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
Departamento de Microbiología, Universidad de Barcelona, Spain.

The complement activation by and resistance to complement-mediated killing of Aeromonas sp. strains from serogroup O:11 were investigated by using different wild-type strains (with an S-layer characteristic of this serogroup) and their isogenic mutants characterized for their surface components (S-layer and lipopolysaccharide [LPS]). All of the Aeromonas sp. serogroup O:11 wild-type strains are unable to activate complement, which suggested that the S-layer completely covered the LPS molecules. We found that the classical complement pathway is involved in serum killing of susceptible Aeromonas sp. mutant strains of serogroup O11, while the alternative complement pathway seems not to be involved, and that the complement activation seems to be independent of antibody. The smooth mutant strains devoid of the S-layer (S-layer isogenic mutants) or isogenic LPS mutant strains with a complete or rather complete LPS core (also without the S-layer) are able to activate complement but are resistant to complement-mediated killing. The reasons for this resistance are that C3b is rapidly degraded, and therefore the lytic membrane attack complex (C5b-9) is not formed. Isogenic LPS rough mutants with an incomplete LPS core are serum sensitive because they bind more C3b than the resistant strains, the C3b is not completely degraded, and therefore the lytic complex (C5b-9) is formed.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000333 Aeromonas A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.
D015941 Complement Hemolytic Activity Assay A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay. CH50 Assay,Complement H50,Hemolytic Titration Assay,Serum Complement Titer,Total Hemolytic Complement,Whole Complement Titer,CH(50),Assay, CH50,Assay, Hemolytic Titration,Assays, CH50,Assays, Hemolytic Titration,CH50 Assays,Complement H50s,Complement, Total Hemolytic,Complements, Total Hemolytic,Hemolytic Complement, Total,Hemolytic Complements, Total,Hemolytic Titration Assays,Serum Complement Titers,Titer, Serum Complement,Titer, Whole Complement,Titers, Serum Complement,Titers, Whole Complement,Titration Assay, Hemolytic,Titration Assays, Hemolytic,Total Hemolytic Complements,Whole Complement Titers

Related Publications

S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
December 1994, Infection and immunity,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
May 1994, FEMS microbiology letters,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
August 1999, Infection and immunity,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
June 1992, Infection and immunity,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
February 1989, Journal of immunology (Baltimore, Md. : 1950),
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
January 1984, Japanese journal of medical science & biology,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
June 1990, Journal of clinical microbiology,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
September 2003, Infection and immunity,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
March 1992, FEMS microbiology letters,
S Merino, and X Rubires, and A Aguilar, and S Albertí, and S Hernandez-Allés, and V J Benedí, and J M Tomas
February 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!